Sahastara Remedy Extract Capsule in Primary Osteoarthritis of Clinical Trial Phase II

• Status: Recruiting
• Trial end date: 2020-10-13
• Target enrollment: 0
• Participant gender: All

Summary

To study efficacy and safety of Sahastara 95% ethanolic extract capsules compared to treatment Primary osteoarthritis for primary osteoarthritis, it was compared with diclofenac (Phase II).

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mr NARIN KAKATUM
• Treatments: Diclofenac

Criteria

Inclusion Criteria:

• No pregnancy

• No Serious Medical Condition evaluated by Physical Examination and Laboratory results in 1 month before study

• No Supplementary food and/or Vitamin during the study Able to follow suggestion during the study

Exclusion Criteria:

• Uncontrolled Hypertension (BP>140/90 mm.Hg.) BMI > 30

• Have serious medical condition including Severe peptic ulcer, congestive heart disease, Liver and Renal dysfunction.

• On during use medicine including Rifampicin, Phenytoin, Propranolol, Theophylline